RESUMEN
BACKGROUND: Malassezia pachydermatis is an opportunistic yeast involved in skin and ear canal infections of dogs and cats. Reports suggest that strains of M. pachydermatis resistant to commonly used antifungal agents may be emerging. Therefore, new therapeutic strategies should be explored. OBJECTIVES: The synergistic effect of oxythiamine (OT) and ketoconazole (KTC) was analysed using a reference strain and field isolates (n = 66) of M. pachydermatis. Hydrogel formulations containing these components also were evaluated. METHODS AND MATERIALS: The minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) of OT, KTC and their mixtures were determined by a broth macrodilution method. The antifungal effects of hydrogel formulations were determined by a plate diffusion method. RESULTS: The MIC and MFC values of OT were in the range 0.08 × 103 to 10 × 103 mg/L. All M. pachydermatis strains showed higher susceptibility to KTC (MICs and MFCs in the range 0.04-0.32 mg/L). Formulations that combined OT and KTC showed a synergistic effect for all tested isolates (n = 66). Hydrogels that contained OT at a concentration of 10 × 103 or 20 × 103 mg/L and KTC at the concentration of 0.1 × 103 mg/L showed a stronger effect than a commercially available product with KTC alone (20 × 103 mg/L). CONCLUSIONS AND CLINICAL IMPORTANCE: Synergy of these drugs may allow for successful topical treatment which utilizes lower doses of KTC without changing its therapeutic effectiveness. Hydrogel formulations proved to be attractive drug carriers for potential topical use.
Asunto(s)
Antifúngicos/uso terapéutico , Dermatomicosis/veterinaria , Enfermedades de los Perros/microbiología , Cetoconazol/uso terapéutico , Malassezia , Otitis Externa/veterinaria , Oxitiamina/uso terapéutico , Animales , Antifúngicos/administración & dosificación , Dermatomicosis/tratamiento farmacológico , Enfermedades de los Perros/tratamiento farmacológico , Perros , Sinergismo Farmacológico , Quimioterapia Combinada , Hidrogel de Polietilenoglicol-Dimetacrilato/administración & dosificación , Cetoconazol/administración & dosificación , Malassezia/efectos de los fármacos , Pruebas de Sensibilidad Microbiana/veterinaria , Otitis Externa/tratamiento farmacológico , Otitis Externa/microbiología , Oxitiamina/administración & dosificaciónRESUMEN
Thiamine plays a very important coenzymatic and non-coenzymatic role in the regulation of basic metabolism. Thiamine diphosphate is a coenzyme of many enzymes, most of which occur in prokaryotes. Pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes as well as transketolase are the examples of thiamine-dependent enzymes present in eukaryotes, including human. Therefore, thiamine is considered as drug or diet supplement which can support the treatment of many pathologies including neurodegenerative and vascular system diseases. On the other hand, thiamine antivitamins, which can interact with thiamine-dependent enzymes impeding their native functions, thiamine transport into the cells or a thiamine diphosphate synthesis, are good propose to drug design. The development of organic chemistry in the last century allowed the synthesis of various thiamine antimetabolites such as amprolium, pyrithiamine, oxythiamine, or 3-deazathiamine. Results of biochemical and theoretical chemistry research show that affinity to thiamine diphosphate-dependent enzymes of these synthetic molecules exceeds the affinity of native coenzyme. Therefore, some of them have already been used in the treatment of coccidiosis (amprolium), other are extensively studied as cytostatics in the treatment of cancer or fungal infections (oxythiamine and pyrithiamine). This review summarizes the current knowledge concerning the synthesis and mechanisms of action of selected thiamine antivitamins and indicates the potential of their practical use.
Asunto(s)
Diseño de Fármacos , Tiamina Pirofosfato/metabolismo , Tiamina/metabolismo , Amprolio/química , Amprolio/metabolismo , Antimetabolitos/uso terapéutico , Transporte Biológico , Humanos , Oxitiamina/antagonistas & inhibidores , Oxitiamina/metabolismo , Piritiamina/antagonistas & inhibidores , Piritiamina/metabolismo , Tiamina/antagonistas & inhibidores , Tiamina/síntesis química , Tiamina Pirofosfato/químicaRESUMEN
Severe skin diseases and systemic fungaemia are caused by Malassezia pachydermatis and Candida albicans respectively. Antifungal therapies are less effective because of chronic character of infections and high percentage of relapses. Therefore, there is a great need to develop new strategies of antifungal therapies. We previously found that oxythiamine decreases proliferation of yeast (Saccharomyces cerevisiae), therefore we suggest that thiamine antivitamins can be considered as antifungal agents. The aim of this study was the comparison of thiamine antivitamins (oxythiamine, amprolium, thiochrome, tetrahydrothiamine and tetrahydrooxythiamine) inhibitory effect on the growth rate and energetic metabolism efficiency in non-pathogenic S. cerevisiae and two potentially pathogenic species M. pachydermatis and C. albicans. Investigated species were cultured on a Sabouraud medium supplemented with trace elements in the presence (40 mg l(-1)) or absence of each tested antivitamins to estimate their influence on growth rate, enzyme activity and kinetic parameters of pyruvate decarboxylase and malate dehydrogenase of each tested species. Oxythiamine was the only antivitamin with antifungal potential. M. pachydermatis and S. cerevisiae were the most sensitive, whereas C. albicans was the least sensitive to oxythiamine action. Oxythiamine can be considered as supportive agent in superficial mycoses treatment, especially those caused by species from the genus Malassezia.
Asunto(s)
Antifúngicos/farmacología , Antimetabolitos/farmacología , Candida albicans/efectos de los fármacos , Candidiasis Cutánea/tratamiento farmacológico , Dermatomicosis/tratamiento farmacológico , Malassezia/efectos de los fármacos , Tiamina/antagonistas & inhibidores , Antifúngicos/uso terapéutico , Antimetabolitos/uso terapéutico , Candida albicans/crecimiento & desarrollo , Candidiasis Cutánea/microbiología , Dermatomicosis/microbiología , Fungemia/tratamiento farmacológico , Fungemia/microbiología , Humanos , Malassezia/crecimiento & desarrollo , Pruebas de Sensibilidad Microbiana , Oxitiamina/farmacología , Oxitiamina/uso terapéutico , Saccharomyces cerevisiae/efectos de los fármacos , Saccharomyces cerevisiae/crecimiento & desarrolloRESUMEN
Malassezia pachydermatis can cause infections of the skin and mucous membranes, especially in animals. It becomes a problem also in medicine. It is considered that metabolic disorders as well as hormonal and immunological status of the host promote diseases caused by M. pachydermatis. Here we consider whether specific features of fungi could also favour infections. We checked whether there are differences in lipid profiles between strains obtained from dogs with otitis externa and strains obtained from healthy dogs. Lipid profiles were determined using thin layer chromatography and gas chromatography-mass spectrometry. All analyses were carried out on 32 strains derived from dogs with otitis externa and 31 strains isolated from dogs without symptoms of disease. The results show that strains isolated from dogs without symptoms of otitis externa are characterised by a higher content of fatty acids. They contain significantly more behenic and lignoceric acids on medium without addition of lipids, and more oleic acid and total monounsaturated fatty acids on medium with lipids supplementation. These strains have also a higher content of esters of ergosterol and triglycerides. Data obtained show differences which may be specific features of M. pachydermatis-specific strains related to the ability of infection, which could be not directly related of the host condition.